Search

everythinglearnresearchcommunity

for

Search:↓

Autoimmune diseases with high tissue recovery often relapse and remit, while those with low recovery rarely remit.

Amotosalen-treated donor T-cells can prevent late CMV infection after bone marrow transplants.

An automated system can predict death risk in thin melanoma by analyzing immune cells.

CD8+ T cells expand significantly in alopecia areata, suggesting new treatment targets.

Skin problems from transplant drugs are common and need careful management in organ transplant patients.

Pembrolizumab can cause serious liver issues, requiring close monitoring and early treatment.

Ixekizumab has known and some unexpected side effects.

Alopecia areata may be caused by the immune system attacking hair follicles.

Psoriasis involves an imbalance between certain immune cells, and targeting these could help restore skin health.

Six months after COVID-19, most patients still had autoantibodies.

Intravital microscopy helps us see how parasites interact with skin and fat in living animals.

The search scheme SMRI is faster and more secure for retrieving encrypted data from the cloud.

A new vaccine using a porous scaffold boosts immunity and protects against the flu better than traditional methods.

CD28 is a promising target for treating alopecia areata with belatacept.

CD28 is a promising target for treating alopecia areata with belatacept.

Early diagnosis, innovative treatments, and considering systemic conditions are crucial in dermatological care.

Imaging intestinal stem cells might help detect early signs of colorectal cancer.

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

Enhancing Tregs can protect against alopecia areata.

CD8+ T cells play a key role in graft-versus-host disease in certain mice models.

The fish oil-based gel with imiquimod improves skin cancer treatment and reduces inflammation.

Transplant success has improved with better immunosuppressive drugs and donor matching.

CD8+ T cells are involved in alopecia areata and may cause disease relapse.

Tumor immunotherapy can cause hair loss by disrupting hair follicle immunity.

Blocking CD44 can reduce leukocyte migration in autoimmune skin diseases.

The document concludes that anti-dsDNA antibodies are not unique to SLE and their use as indicators is doubtful, highlighting the need for better understanding and classification of the disease.

Type-2 immunity may influence skin diseases and could be targeted for treatment.

Rapamycin increased survival in mice with severe chronic graft-versus-host disease by expanding regulatory T cells.